These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10529512)

  • 21. Complement receptor type 1 (CR1) deficiency on neutrophils in myelodysplastic syndrome.
    Ohsaka A; Saionji K; Watanabe N; Yokomichi H; Sugahara Y; Nagayama R; Igari J
    Br J Haematol; 1994 Oct; 88(2):409-12. PubMed ID: 7803293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
    Ghaddar HM; Stass SA; Pierce S; Estey EH
    Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M; Yamauchi H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia.
    Kyriakou D; Eliopoulos AG; Alexandrakis M; Kalokyri I; Eliopoulos GD
    Haematologia (Budap); 1996; 28(1):1-7. PubMed ID: 9283897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absent or extremely low neutrophil alkaline phosphatase activity levels in patients with myelodysplastic syndromes.
    Yoshida Y; Katsurada T; Oguma S; Nakabo Y; Yoshinaga N; Kawahara M; Kawabata H
    Intern Med; 2013; 52(4):479-82. PubMed ID: 23411705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].
    Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
    Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F; Hao Y; Pang W
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].
    Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
    Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
    J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes.
    Luo SS; Ogata K; Yokose N; Kato T; Dan K
    Stem Cells; 2000; 18(2):112-9. PubMed ID: 10742383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloperoxidase-deficient polymorphonuclear leucocytes. (V): Relation to FAB-classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes.
    Bendix-Hansen K; Kerndrup G
    Scand J Haematol; 1985 Aug; 35(2):197-200. PubMed ID: 2996123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and cytogenetic features of 29 cases of myelodysplastic syndrome associated with del(20q)].
    Qin S; Liu SH; Bo LJ; Liu XP; Li CW; Dai Y; He GS; Shao ZH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):171-2. PubMed ID: 15079804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes].
    Akiba M; Matsuda A; Misumi M; Yagasaki F; Bessho M
    Rinsho Ketsueki; 2001 Dec; 42(12):1162-9. PubMed ID: 11828718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Wilms' tumor-1 gene expression in myelodysplastic syndrome and its changes in the process of myelodysplastic syndrome transforming into acute leukemia].
    Yang JK; Li JL; Li ZG; Li ZG; Liu PJ; Li JY; Lü HR; Deng Q; Lin XM; Cao JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):557-9. PubMed ID: 12971856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
    Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
    Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection in the myelodysplastic syndromes.
    Pomeroy C; Oken MM; Rydell RE; Filice GA
    Am J Med; 1991 Mar; 90(3):338-44. PubMed ID: 2003516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombopoietin and myelodysplastic syndromes.
    Ogata K; Tamura H
    Int J Hematol; 2000 Aug; 72(2):173-7. PubMed ID: 11039665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.